{
    "2018-10-10": [
        [
            {
                "time": "2018-01-02",
                "original_text": "Johnson & Johnson (JNJ) Stock Moves -1.06%: What You Should Know",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Stock Moves",
                        "-1.06%"
                    ],
                    "sentiment_score": -0.53,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "5 Healthcare Stocks to Buy for Complete Portfolio Wellness",
                "features": {
                    "keywords": [
                        "Healthcare Stocks",
                        "Buy",
                        "Portfolio Wellness"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Alexion Pharmaceuticals’ Operational Performance",
                "features": {
                    "keywords": [
                        "Alexion Pharmaceuticals",
                        "Operational Performance"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Analyzing Alexion Pharmaceuticals’ Top-Line Trends",
                "features": {
                    "keywords": [
                        "Alexion Pharmaceuticals",
                        "Top-Line Trends"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "How Alexion Pharmaceuticals Is Positioned in October",
                "features": {
                    "keywords": [
                        "Alexion Pharmaceuticals",
                        "Positioned",
                        "October"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Arbutus (ABUS) Plunges on Disappointing HBV Pipeline Updates",
                "features": {
                    "keywords": [
                        "Arbutus",
                        "Plunges",
                        "Disappointing",
                        "HBV Pipeline Updates"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "J&J's Stelara Succeeds in Phase III Ulcerative Colitis Study",
                "features": {
                    "keywords": [
                        "J&J",
                        "Stelara",
                        "Succeeds",
                        "Phase III",
                        "Ulcerative Colitis Study"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "J&J’s Stelara Succeeds in Phase III Ulcerative Colitis Study",
                "features": {
                    "keywords": [
                        "J&J",
                        "Stelara",
                        "Succeeds",
                        "Phase III",
                        "Ulcerative Colitis Study"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "How Novartis’s Sandoz Business Has Been Performing Recently",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Sandoz",
                        "Performing"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Health Care Sector Update for 10/10/2018: IGC, AKRX, JNJ, PFE, ABT, MRK, AMGN",
                "features": {
                    "keywords": [
                        "Health Care Sector",
                        "Update",
                        "IGC",
                        "AKRX",
                        "JNJ",
                        "PFE",
                        "ABT",
                        "MRK",
                        "AMGN"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "How Intuitive’s Bottom Line Is Expected to Look in Q3 2018",
                "features": {
                    "keywords": [
                        "Intuitive",
                        "Bottom Line",
                        "Q3 2018"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Why Most Analysts Are Bullish on Intuitive Surgical in October",
                "features": {
                    "keywords": [
                        "Analysts",
                        "Bullish",
                        "Intuitive Surgical",
                        "October"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "10 S&P 500 Stocks to Buy for the Long-Term",
                "features": {
                    "keywords": [
                        "S&P 500 Stocks",
                        "Buy",
                        "Long-Term"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "general"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}